These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16767774)

  • 1. Intravenous immunoglobulin enhances the clearance of fibrillar amyloid-beta peptide.
    Istrin G; Bosis E; Solomon B
    J Neurosci Res; 2006 Aug; 84(2):434-43. PubMed ID: 16767774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin and Alzheimer's disease immunotherapy.
    Solomon B
    Curr Opin Mol Ther; 2007 Feb; 9(1):79-85. PubMed ID: 17330405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic acid enhances microglial phagocytosis of amyloid-beta(1-42).
    Smith AM; Gibbons HM; Dragunow M
    Neuroscience; 2010 Aug; 169(1):505-15. PubMed ID: 20423723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease.
    Relkin NR; Szabo P; Adamiak B; Burgut T; Monthe C; Lent RW; Younkin S; Younkin L; Schiff R; Weksler ME
    Neurobiol Aging; 2009 Nov; 30(11):1728-36. PubMed ID: 18294736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum-derived immunoglobulins alter amyloid beta transport across a blood-brain barrier in vitro model.
    Poetsch V; Bennani-Baiti B; Neuhaus W; Muchitsch EM; Noe CR
    Pharmazie; 2010 Apr; 65(4):267-73. PubMed ID: 20432623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium dyshomeostasis and neurotoxicity of Alzheimer's beta-amyloid protein.
    Kawahara M; Negishi-Kato M; Sadakane Y
    Expert Rev Neurother; 2009 May; 9(5):681-93. PubMed ID: 19402778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of intravenous immunoglobulins for naturally occurring autoantibodies against amyloid-beta.
    Balakrishnan K; Andrei-Selmer LC; Selmer T; Bacher M; Dodel R
    J Alzheimers Dis; 2010; 20(1):135-43. PubMed ID: 20164596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minocycline does not affect amyloid beta phagocytosis by human microglial cells.
    Familian A; Eikelenboom P; Veerhuis R
    Neurosci Lett; 2007 Apr; 416(1):87-91. PubMed ID: 17317005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural human antibodies to amyloid beta peptide.
    Szabo P; Relkin N; Weksler ME
    Autoimmun Rev; 2008 Jun; 7(6):415-20. PubMed ID: 18558354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal peptide protects against beta-amyloid-induced neurodegeneration by inhibiting microglia activation at multiple levels.
    Delgado M; Varela N; Gonzalez-Rey E
    Glia; 2008 Aug; 56(10):1091-103. PubMed ID: 18442091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum-derived immunoglobulins neutralize adverse effects of amyloid-beta peptide on the integrity of a blood-brain barrier in vitro model.
    Poetsch V; Neuhaus W; Noe CR
    J Alzheimers Dis; 2010; 21(1):303-14. PubMed ID: 20421696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Conformational change, pore formation and neurotoxicity of amyloidogenic proteins].
    Kawahara M
    Rinsho Byori; 2008 Feb; 56(2):130-6. PubMed ID: 18404827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglial transplantation increases amyloid-beta clearance in Alzheimer model rats.
    Takata K; Kitamura Y; Yanagisawa D; Morikawa S; Morita M; Inubushi T; Tsuchiya D; Chishiro S; Saeki M; Taniguchi T; Shimohama S; Tooyama I
    FEBS Lett; 2007 Feb; 581(3):475-8. PubMed ID: 17240371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active immunization against Alzheimer's beta-amyloid peptide using phage display technology.
    Solomon B
    Vaccine; 2007 Apr; 25(16):3053-6. PubMed ID: 17287054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications.
    El Khoury J; Luster AD
    Trends Pharmacol Sci; 2008 Dec; 29(12):626-32. PubMed ID: 18835047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of intravenous immunoglobulin action in immune thrombocytopenic purpura.
    Jin F; Balthasar JP
    Hum Immunol; 2005 Apr; 66(4):403-10. PubMed ID: 15866704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of conformational antibodies on dissociation of fibrillar amyloid beta (A beta 1-42) in vitro.
    Subramanian S; Madhavadas S; Balasubramanian P
    Indian J Exp Biol; 2009 May; 47(5):309-13. PubMed ID: 19579793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of cryptic IgG reactive with BAFF, amyloid beta peptide and GM-CSF during the industrial fractionation of human plasma into therapeutic intravenous immunoglobulins.
    St-Amour I; Laroche A; Bazin R; Lemieux R
    Clin Immunol; 2009 Oct; 133(1):52-60. PubMed ID: 19604724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
    Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
    Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tripchlorolide protects neuronal cells from microglia-mediated beta-amyloid neurotoxicity through inhibiting NF-kappaB and JNK signaling.
    Pan XD; Chen XC; Zhu YG; Chen LM; Zhang J; Huang TW; Ye QY; Huang HP
    Glia; 2009 Aug; 57(11):1227-38. PubMed ID: 19170180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.